The induced pluripotent stem cells (iPSC)-derived neural stem cells from PD patients harboring the LRRK2 G2019S mutation showed altered Ca2+ dynamics and mitochondrial DNA damage; however, all disease phenotypes were rescued via LRRK2 inhibition [200,201]. The gene discussed is LRRK2; the disease is Parkinson disease.